Luke Nicholson
87 posts
@LukeNic17
Ophthalmologist specialising in Medical Retina based in London, UK
Delighted to share our study on #PAMM and risk of systemic vascular diseases, now published in @AJOphthalmology 👀🔍🫀. Privileged to be part of such a great group! @LaxmiDRaja @sktywagner @praveenjpatel @LukeNic17 @pearsekeane @h_a_khalid @JosefHuemer1 doi.org/10.1016/j.ajo.…
Now this is what success looks like… Mega congratulations 2 Dr. Ms. Dr @CjShruti on successfully defending your #PhD #Thesis. No corrections! Title: Phenotypic Heterogeneity & its influence on visual & morphological outcomes in age-related macular degeneration. #One2Watch 🥳
Congrats to 2023 @ARVOinfo Advocacy Awards winners—@CrosbyNwaobi/@MoorfieldsBRC, @NIHRresearch (Achievements in Eye and #VisionAdvocacy Award) and Rohan Bir Singh, MD/@MassEyeAndEar, @harvardmed (Emerging Advocate Award). Read about these amazing awardees: bit.ly/499dAII
Congratulations to Siegfried Wagner, vitreoretinal fellow at Moorfields, who has been named among 10 Rising Stars by The Ophthalmologist Power List. Read more about Siegfried's work and why he's one to look out for: moorfields.nhs.uk/news/ophthalmo… @sktywagner
Brought another one home, Mama! Thank you to my patients, their families and their communities! 👏🏾👏🏾 I could not do what I do without you!
Really honoured to be awarded Digital and Data Champion 2022 by @NHSEngland 😊 Embracing #digital health technologies in safe, evidence-based and inclusive ways is key for better patient care in real-life!@NHSTransform @Moorfields @MoorfieldsBRC
And now.. the EURETINA Lecture 2022 by Prof Sobha Sivaprasad #EURETINA2022
OPEN ACCESS RETINAL NONPERFUSION IN THE EARLY TREATMENT DIABETIC RETINOPATHY STUDY 7 FIELDS COMPARED WITH WIDEFIELD FLUORESCEIN ANGIOGRAPHY Correlation & Use of Extrapolation Factor Martin-Gutierrez, M. P. MD; et. al. Aug 2022 Vol 42(8) p1592-8 journals.lww.com/retinajournal/… #retina
